Suppr超能文献

癌症患者的白细胞和血小板含有高水平的血管内皮生长因子。

Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor.

作者信息

Salven P, Orpana A, Joensuu H

机构信息

Department of Oncology, Helsinki University Central Hospital, Finland.

出版信息

Clin Cancer Res. 1999 Mar;5(3):487-91.

Abstract

Vascular endothelial growth factor (VEGF) is a secreted endothelial cell-specific mitogen and permeability factor. Malignant human tumors have been shown to produce VEGF. Elevated levels of VEGF have been detected in sera of cancer patients, but its origin is unsettled. We analyzed VEGF concentrations in serum, plasma, whole blood, and peripheral blood mononuclear cells (PBMNCs) and platelets in 56 cancer patients and 52 healthy controls using ELISA. The VEGF concentrations in the lysed whole blood samples [blood VEGF (B-VEGF)] were higher in cancer patients than in healthy controls (median, 464 versus 298 pg/ml; P<0.0001). The highest B-VEGF values were found in disseminated cancer. In cancer patients, a high B-VEGF concentration was associated with a high peripheral blood leukocyte count (P = 0.0012) and platelet count (P = 0.019). In healthy individuals, a high B-VEGF was associated with a high leukocyte count (P = 0.0001) but not with the platelet count (P>0.1). The cancer patients regularly had higher B-VEGF concentrations than healthy individuals with comparable leukocyte or platelet counts. The VEGF content of isolated PBMNCs and platelets was severalfold higher in cancer patients than in healthy controls (median, 10.6 versus 0.9 pg per 10(6) PBMNCs, and median, 1.6 versus 0.5 pg per 10(6) platelets; P<0.0001 and P = 0.0008, respectively). Serum VEGF and B-VEGF correlated strongly (P<0.0001). Very little or no VEGF was found in the plasma. The results indicate that VEGF in the bloodstream is transported by blood cells, including leukocytes and platelets. The blood cells of cancer patients contain greatly elevated amounts of this major angiogenic growth factor, and this reservoir of VEGF may have a role in tumor angiogenesis and metastasis formation. VEGF in serum samples originates from blood cells, and the use of VEGF of whole blood or of isolated blood cells may improve the clinical value of VEGF measurements.

摘要

血管内皮生长因子(VEGF)是一种分泌型内皮细胞特异性促有丝分裂原和通透性因子。已证实人类恶性肿瘤可产生VEGF。在癌症患者血清中检测到VEGF水平升高,但其来源尚不确定。我们使用酶联免疫吸附测定法(ELISA)分析了56例癌症患者和52例健康对照者血清、血浆、全血、外周血单个核细胞(PBMNCs)及血小板中的VEGF浓度。癌症患者裂解全血样本中的VEGF浓度[血液VEGF(B-VEGF)]高于健康对照者(中位数分别为464和298 pg/ml;P<0.0001)。在播散性癌症中发现B-VEGF值最高。在癌症患者中,高B-VEGF浓度与高外周血白细胞计数(P = 0.0012)和血小板计数(P = 0.019)相关。在健康个体中,高B-VEGF与高白细胞计数相关(P = 0.0001),但与血小板计数无关(P>0.1)。癌症患者的B-VEGF浓度通常高于白细胞或血小板计数相当的健康个体。癌症患者分离的PBMNCs和血小板中的VEGF含量比健康对照者高几倍(中位数分别为每10^6个PBMNCs中10.6和0.9 pg,以及每10^6个血小板中1.6和0.5 pg;P分别<0.0001和P = 0.0008)。血清VEGF与B-VEGF高度相关(P<0.0001)。血浆中发现很少或没有VEGF。结果表明,血流中的VEGF由包括白细胞和血小板在内的血细胞运输。癌症患者的血细胞中这种主要血管生成生长因子的含量大幅升高,VEGF的这一储存库可能在肿瘤血管生成和转移形成中起作用。血清样本中的VEGF来源于血细胞,使用全血或分离血细胞的VEGF可能会提高VEGF测量的临床价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验